New Translational Insights on Metabolic Syndrome: Obesity, Hypertension, Diabetes and Beyond
Metabolic syndrome (MetS) can be considered as a clustering of several risk factors such as obesity, hypertension, insulin resistance and dyslipidemia, which could lead to the development of diabetes and cardiovascular diseases (CVD). There are several underlying causes for MetS including overweight...
Format: | eBook |
---|---|
Language: | English |
Published: |
Frontiers Media SA
2016
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | Open Access: DOAB, download the publication Open Access: DOAB: description of the publication |
Similar Items
-
Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity
by: Mihnea A. Găman, et al.
Published: (2019-05-01) -
A closer look at the role of urotensin II in the metabolic syndrome
by: Pierre-Olivier eBarrette, et al.
Published: (2012-12-01) -
Adiponectin: an adipokine with protective features against metabolic syndrome
by: Maryam Esfahani, et al.
Published: (2015-05-01) -
Association between Metabolically Healthy Obesity and Subclinical Atherosclerosis in the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort
by: Ahn, S.H, et al.
Published: (2022) -
Association between Sarcopenic Obesity, Type 2 Diabetes, and Hypertension in Overweight and Obese Treatment-Seeking Adult Women
by: Dima Kreidieh, et al.
Published: (2018-10-01)